Biotech

All Articles

Bicara, Zenas seek IPOs to drive late-phase assets toward market

.Bicara Therapeutics and also Zenas Biopharma have given fresh catalyst to the IPO market along with...

Genentech to close cancer immunology investigation team

.Genentech will shut its cancer cells immunology study team, as well as device mind as well as promi...

Kezar drops strong growth yet to verify its own worth in period 1 trial

.Kezar Life Sciences is actually losing its unpromising phase 1 sound lump drug as the biotech goes ...

Acelyrin loses izokibep, lets go 3rd of staff

.Even with izokibep sustaining its newly found winning touch in the clinic, Acelyrin is no longer co...

Rivus' stage 2 obesity-related heart failure trial reaches endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its own fat-busting, muscle-sparing drug cand...

Ovid halts preclinical job, IV program after soticlestat neglect

.Ovid Rehab currently uncovered last month that it was actually trimming its headcount as the provid...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has opened up a $700 thousand R&ampD center in the Boston ma Port, boosting its own RNA a...

Boundless Bio makes 'reasonable' discharges 5 months after $100M IPO

.Only 5 months after protecting a $100 thousand IPO, Vast Biography is actually laying off some work...

Halda's $126M will certainly advance 'hold and also get rid of' tumor medicines

.The first stages of oncology R&ampD may not be short of appealing new modalities, and also Halda Th...

Lykos 'regrets' certainly not revealing research study transgressions along with author

.Psychopharmacology has actually pulled three articles regarding midstage clinical trial records ana...